FEATURED, Research, Breast Cancer
ONCOTYPE Dx MAY GUIDE A NEOADJUVANT APPROACH FOR AXILLARY DOWNSTAGING IN ER+/HER2- BREAST CANCER
Few studies have examined the utility of Oncotype Dx Recurrence Score® (RS) in predicting tumor response in the neoadjuvant setting. While neoadjuvant chemother...
FEATURED, Research, Breast Cancer
DISEASE FREE SURVIVAL IN LOBULAR BREAST CANCER IS IMPACTED BY Ki67 BUT NOT RECURRENCE SCORE
In a vast majority of cases, invasive lobular carcinoma (ILC) is hormone receptor positive and Her2 negative. It is generally an indolent disease and, in many s...
FEATURED, Research, Breast Cancer, Risk
Please Don't Say it's Food! Nutrients and Breast Cancer Risk
Studies trying to pin breast cancer risk to intake of various food groups have been to say the least, inconsistent. The authors performed a nutrient-wide associ...
FEATURED, Research, Breast Cancer
Peripheral Papillomas Diagnosed by Core Biopsy: To Excise or Not Excise
I believe that it is fair to say that most surgeons excise peripheral papillary mass lesions diagnosed by core needle biopsy. This approach has been challenged ...
FEATURED, Research, Germline, Breast Cancer
Inflammatory Breast Cancer May Be At High Risk of Germline Mutation
Study suggests that patients with inflammatory breast cancer may be at high risk of germline mutation The observation that inflammatory breast cancer (IBC) is m...
FEATURED, Research, Pregnancy, Breast Cancer
THE GENOMIC LANDSCAPE OF BREAST CANCERS FOLLOWING PREGNANCY
TP53 mutations more common cancers following early pregnancy
